Benefit of Clarithromycin in Patients With Severe Infections Through Modulation of the Immune System

Clinical trial NCT03345992 · COMPLETED

Trial details

NCT number: NCT03345992
Sponsor: Hellenic Institute for the Study of Sepsis
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Sepsis Pneumonia Gram-Negative Bacteria Infection Multiple Organ Failure Respiratory Distress Syndrome Mortality Biomarkers

Start date: 2017-12-15
Primary completion: 2019-09-22
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.